Personalized radiation therapy for early breast cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing a way to personalize radiation therapy for people with early-stage breast cancer. It may help make treatment more precise and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman with a specific type of breast cancer called 'unifocal infiltrating ductal carcinoma'.
- Your cancer must be at an early stage (T1 or T2) and not have spread to lymph nodes (N0).
- You must be able to have an MRI scan (no metal implants from knee to shoulder, no pacemaker, etc.).
- You must be in reasonably good health (able to care for yourself, ECOG 0-2).
- You must be over 18 years old and planning to have active treatment (like surgery, radiation, or cryoablation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This study tests a precise type of radiation (stereotactic radiotherapy) for men with early-stage prostate cancer. It aims to see if using custom radiation beams improves outcomes while reducing side effects.
This trial tests a shorter radiation plan using an MRI machine to guide treatment. The goal is to see if two high-dose sessions work just as well as longer treatment, with fewer side effects. It is for men with low or intermediate risk prostate cancer.
This trial studies a “daily adaptive” way of planning and delivering radiation after prostate surgery to treat prostate cancer that is coming back locally. It may help target the tumor more precisely while limiting radiation to healthy tissue.
This trial tests a new type of CT scan that might help doctors see tumors more clearly in tricky areas like the brain, head, neck, liver, pancreas, or prostate. It also looks at people with heart disease who need radiation therapy. The goal is to make radiation treatment more accurate and personalized.
Hear when a new Breast Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.